Written and maintained by CASRAI Editorial Board
Published · Last updated
This page describes products and general use; it is not medical advice.
On this page
Cerebral oximetry is the noninvasive, sensor-based measurement of the oxygen saturation of hemoglobin in the brain tissue beneath a sensor, using near-infrared light (NIRS). In the United States the device is called a cerebral oximeter and is regulated by FDA as a Class II device under 21 CFR 870.2700, with its own product code, QEM. It is used by hospital clinical staff; this page also helps buyers and students tell a cerebral oximeter from a fingertip pulse oximeter and read FDA’s records for the category.
What a cerebral oximeter is
A cerebral oximeter is a monitor with an adhesive sensor placed on the skin over the brain that reports regional hemoglobin oxygen saturation of blood in the tissue beneath the sensor. The FDA-cleared labelling for one such system (Mespere VO200 NeurOs, K182242) states it is intended as an adjunct trend monitor of regional hemoglobin oxygen saturation of blood in the brain tissue beneath the sensor, that the prospective clinical value of its data has not been demonstrated in disease states, and that it should not be used as the sole basis for diagnosis or therapy.
The regulation that covers the category, 21 CFR 870.2700, defines an oximeter as a device used to transmit radiation at a known wavelength through blood and to measure blood oxygen saturation from the amount of reflected or scattered radiation. It may be used alone or with a fiberoptic oximeter catheter. Cerebral oximeters, tissue (regional) oximeters and pulse oximeters all sit under this one regulation, which is why the product code matters (see the table below).
How a NIRS cerebral oximeter works
A NIRS (near-infrared spectroscopy) sensor shines near-infrared light into the tissue and detects the light that returns. A 2021 review in Healthcare (Zhong et al.) notes that Jobsis published the tissue-penetration property of near-infrared light in Science in 1977, that within the optical window of 700-950 nm the penetration depth can reach several centimeters, and that a modified Lambert-Beer law (Cope and Delpy) accounts for scattering through a differential path factor. The same review calls NIRS the only noninvasive bedside technique for monitoring cerebral blood oxygen saturation.
Because the light travels through scalp and skull as well as brain, the review warns that extracranial tissues can interfere considerably with the signal and that extracranial circulation may contaminate NIRS results.
FDA classification and product codes
Under 21 CFR 870.2700 (checked 2026-10-30 at Cornell LII) oximeters are Class II (performance standards). openFDA’s classification database (last updated 2026-10-19) lists several product codes under this regulation. The one named for this device is QEM, Cerebral Oximeter, defined as an oximeter to measure cerebral tissue saturation.
| Product code | FDA name | Class | What FDA’s record says |
|---|---|---|---|
| QEM | Cerebral Oximeter | 2 | Oximeter to measure cerebral tissue saturation |
| MUD | Oximeter, Tissue Saturation | 2 | Several of the regional and cerebral oximeter systems listed below were cleared under this code |
| DQA | Oximeter | 2 | The general oximeter code, which includes pulse oximeters |
| NMD | Oximeter, Tissue Saturation, Reprocessed | 2 | Reprocessing validation data must be included in a 510(k) submission |
| OLK | Pulse Oximeter For Over-The-Counter Use | 2 | Non-wearable fingertip pulse oximeter for over-the-counter use |
Source: openFDA device classification API, regulation number 870.2700, checked 2026-10-30. For how FDA clearance differs from approval, see cleared vs approved pulse oximeters.
Cleared systems and sensors (examples)
The table lists examples from FDA’s 510(k) database (openFDA, checked 2026-10-30). It is an illustration of what appears in the record, not a ranking or a recommendation.
| System | 510(k) number | Decision date | Applicant |
|---|---|---|---|
| INVOS 3100A Cerebral Oximeter | K971628 | 1997-10-10 | Somanetics Corp. |
| INVOS PM7100 Patient Monitor, Adult rSO2 Sensor | K182868 | 2019-01-08 | Covidien, LLC |
| INVOS PM7100 with Pediatric and Infant sensors | K211561 | 2021-12-05 | Covidien, LLC |
| SenSmart regional oximetry sensors (8006CA, 8006PI) | K190560 | 2019-05-02 | Nonin Medical, Inc. |
| VO200 NeurOs Cerebral Oximetry System | K182242 | 2018-12-26 | Mespere Lifesciences, Inc. |
| FORE-SIGHT ELITE Absolute Tissue Oximeter | K203490 | 2021-02-10 | Edwards Lifesciences, LLC |
| Masimo O3 Regional Oximeter | K243324 | 2025-07-17 | Masimo Corporation |
Where the name Somanetics fits
Somanetics Corp. is the applicant on the 1997 INVOS 3100A 510(k) (K971628) and, in FDA’s record, the INVOS 5100 (K001842, 2000-09-15). The later INVOS PM7100 clearances in the table are held by Covidien, LLC.
What the labelling says about use
- Adjunct, trend monitoring. The VO200 labelling describes an adjunct trend monitor and says the data should not be the sole basis for diagnosis or therapy (K182242 Indications for Use, checked 2026-10-30).
- Cerebral and somatic sites. FDA’s letter for the INVOS PM7100 (K182868) describes a noninvasive cerebral/somatic oximetry system, an adjunct monitor of regional hemoglobin oxygen saturation in the brain or in other tissue beneath the sensor.
- Single patient use and matched sensors. For that system, the Adult rSO2 Sensor is indicated for single patient use and is only intended to be used with INVOS near-infrared spectroscopy technology. A sensor made for one platform is therefore not a generic part.
Limits of the reading
The Zhong et al. review reports that different commercial monitors tend to use different algorithms, that it is therefore difficult to compare monitoring results across equipment, and that no standards have yet been established. In practice this means a saturation number from one brand is not directly interchangeable with the same number from another.
Safe use and handling basics
- Use the sensor and monitor combination the manufacturer’s instructions for use name; check which sensors are labelled single patient use and do not reuse those.
- Follow the facility’s infection-control policy and the manufacturer’s cleaning instructions for any reusable cable or monitor.
Common mistakes
- Treating it as a pulse oximeter. FDA files them under different product codes (QEM and MUD for cerebral and tissue oximeters, DQA for the general oximeter code that includes pulse oximeters). See the guides on what a pulse oximeter is and pulse oximeter types; for another monitoring modality, see capnography.
- Comparing values across brands. Algorithms differ and no cross-device standard exists, per the review above.
- Using the number as the sole basis for decisions. The cleared labelling calls it an adjunct.
- Mixing sensors and monitors from different platforms. The INVOS adult sensor is labelled for use only with INVOS NIRS technology.
Facilities that stock monitoring equipment can browse diagnostic, monitoring and imaging supplies.
FAQ
What is a cerebral oximeter?
A cerebral oximeter is a noninvasive monitor that uses a near-infrared sensor on the skin to report regional hemoglobin oxygen saturation of blood in the brain tissue beneath the sensor. FDA classifies it as Class II with product code QEM under 21 CFR 870.2700.
What is a NIRS sensor, and what does NIRS cerebral mean?
NIRS is near-infrared spectroscopy. A NIRS sensor emits near-infrared light and detects what returns through the tissue; a cerebral NIRS sensor is placed to measure brain tissue saturation. Sensors are labelled for specific monitors, so check compatibility with the manufacturer’s instructions.
What is Somanetics?
Somanetics Corp. was the applicant for the original INVOS cerebral oximeter 510(k) clearances in FDA’s database (K971628 in 1997, K001842 in 2000). Later INVOS clearances list Covidien, LLC.
Is cerebral oximetry the same as pulse oximetry?
No. Both use light and fall under 21 CFR 870.2700, but FDA assigns them different product codes, and a cerebral oximeter reports regional saturation in the tissue beneath its sensor.
Sources
- 21 CFR 870.2700, Oximeter, Cornell LII (https://www.law.cornell.edu/cfr/text/21/870.2700), checked 2026-10-30.
- openFDA device classification API, regulation number 870.2700 (https://api.fda.gov/device/classification.json), checked 2026-10-30.
- openFDA device 510(k) API (https://api.fda.gov/device/510k.json), checked 2026-10-30.
- FDA 510(k) K182242 letter and Indications for Use (https://www.accessdata.fda.gov/cdrh_docs/pdf18/K182242.pdf), checked 2026-10-30.
- FDA 510(k) K182868 letter (https://www.accessdata.fda.gov/cdrh_docs/pdf18/K182868.pdf), checked 2026-10-30.
- Zhong et al., A Review of Monitoring Methods for Cerebral Blood Oxygen Saturation, Healthcare 2021;9(9):1104, https://doi.org/10.3390/healthcare9091104, checked 2026-10-30.







